NewGen BioPharma Corp. (NEWG)

[Renee]

NEWG SEC Suspension:

https://www.sec.gov/litigation/suspensions/2017/34-80318.pdf

Order:

https://www.sec.gov/litigation/suspensions/2017/34-80318-o.pdf

The Commission temporarily suspended trading in the securities of NewGen BioPharma because of questions regarding the accuracy and adequacy of publicly available information about the company, specifically (i) the identity of its former sole executive officer, director, and majority
shareholder; and (ii) possible undisclosed former and current controlling persons.

From the ORDER:

It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of NewGen BioPharma Corp. (CIK No.0001537274) because of questions regarding the accuracy and adequacy of publicly available information, in periodic and other reports, about the company since at least January 9, 2014, specifically (i) the identity of its former sole executive officer, director, and majority shareholder; and (ii) possible undisclosed former and current controlling persons. NewGen BioPharma Corp. is a Nevada corporation whose current principal place of business is in Seattle,
Washington. Its stock is quoted on OTC Link LLC, operated by OTC Markets Group, Inc., under the ticker symbol NEWG.